Martin L. Yarmush, M.D., Ph.D.
Chief Scientific Adviser
martinyarmush
Professor Yarmush is an internationally recognized bioengineer and biophysical chemist whose laboratory has been a leader in the fields of tissue engineering and microfabrication. Dr. Yarmush currently serves as the Paul and Mary Monroe Professor of Science and Engineering and Distinguished Professor of Biomedical and Chemical Engineering in the School of Engineering at Rutgers University; as the Director of the Center for Innovative Ventures of Emerging Technologies (CIVET) at Rutgers; and as the Director of the Center for Engineering in Medicine at the Massachusetts General Hospital/Harvard Medical School. Over the last 30 years, Dr. Yarmush has published more than 400 refereed journal articles, has mentored over 140 postdoctoral fellows and graduate students, and has co-authored more than 40 patents and patent applications. A frequent invited speaker at major conferences and symposia, and winner of over 25 local and national awards, Dr. Yarmush is known worldwide as one of the leading investigators in the area of molecular and cellular bioengineering through seminal contributions to the fields of tissue engineering and regenerative medicine, BioMEMS, applied immunology, metabolic engineering, and genomics and proteomics technologies. Advances with which he has been credited include innovative cell culture systems, microfabricated bioartificial organs development, targeted therapies for tumors and infections, recombinant protein and recombinant retrovirus production and purification techniques, and microfabricated living cell arrays. Dr. Yarmush received his MD degree from Yale University and completed PhD work at The Rockefeller University (physical biochemistry) and MIT (chemical engineering).
BioMEMS, applied immunology, metabolic engineering, and genomics and proteomics technologies. Advances with which he has been credited include innovative cell culture systems, microfabricated bioartificial organs development, targeted therapies for tumors and infections, recombinant protein and recombinant retrovirus production and purification techniques, and microfabricated living cell arrays. Dr. Yarmush received his MD degree from Yale University and completed PhD work at The Rockefeller University (physical biochemistry) and MIT (chemical engineering).